Physician profile

Andrew Eric Smith

Dentist · Menomonee Falls, WI

NPI 1265662753

$542.72

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$119.23
Education$21.40

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Dentsply Ih INC. $111.38 2019
Philips North America LLC $91.06 2022
Align Technology, INC. $90.10 2020
Dentsply Sirona INC $83.08 2022
Kerr Corporation $47.70 2023 Optibond Xtr
Nobel Biocare USA $47.69 2023 Nobelactive
Vanda Pharmaceuticals INC. $23.84 2023 Fanapt, Hetlioz
Gc America INC. $21.40 2023 G-Aenial
Kulzer, LLC $15.19 2022
Dentsply Sirona Orthodontics INC $11.28 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Andrew Eric Smith

$542.72

in general payments reported 2019-2025

Years
2019-2023
Top company
Dentsply Ih INC.

https://glasscript.com/doctor/1054598/andrew-eric-smith

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.